Autoimmune Diseases  >>  trichuris suis ova (CNDO-201)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
trichuris suis ova (CNDO-201) / Fortress
TRIMS A, NCT01006941: Trichuris Suis Ova Therapy for Relapsing Multiple Sclerosis - a Safety Study

Completed
2
10
Europe
Trichuris suis ova, TSO
Rigshospitalet, Denmark, University of Copenhagen, Statens Serum Institut, Copenhagen University Hospital, Hvidovre, OvaMed GmbH
Relapsing Multiple Sclerosis
01/11
09/11
TRIOMS, NCT01413243: Trichuris Suis Ova (TSO)in Recurrent Remittent Multiple Sclerosis and Clinically Isolated Syndrome

Terminated
2
50
Europe
Trichuris suis ova, TSO
Charite University, Berlin, Germany
Multiple Sclerosis
12/16
06/17

Download Options